All News

Outlining the common data transactions between life sciences companies and the HIPAA-regulated stakeholders they deal with daily-and steps pharma can take to secure and protect its own data.

Click the title above to open the Pharmaceutical Executive November 2017 issue in an interactive PDF format.

Navigating Data Privacy and Security Considerations in the Life Sciences Industry

Brenda Gleason discusses the current health policy landscape and how future pharmacists can be healthcare leaders during a lecture at University of North Carolina Eshelman School of Pharmacy.

Click the title above to open the Pharmaceutical Executive October 2017 issue in an interactive PDF format.

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways.

A big thank you to you, our readers, for lending your voice to Pharm Exec's editorial mission-giving you the information you need and want. Click ahead for a look at some of the future topics we'll be tackling.

Is report worth a look as potential springboard to addressing future EU ties in healthcare-or just more bluster?